Pfeifer, Walther
Pfeifer, Walther was paid $107K by Medicaid between Aug 2020 and Oct 2023, across 47 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 23% of everything it billed.
BOSTON, MA 02118
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Massachusetts
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,502 | $27K | |
| 2021 | 298 | $9K | |
| 2022 | 497 | $10K | |
| 2023 | 5,624 | $61K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 23% | 253 | 221 | $24K |
| 80050 | General health panel | 8.9% | 331 | 328 | $10K |
| 80061 | Lipid panel | 6.5% | 637 | 636 | $7K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 6.3% | 273 | 270 | $7K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 5.9% | 165 | 164 | $6K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5.8% | 159 | 158 | $6K |
| 86480 | 3.8% | 155 | 152 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | 3.2% | 245 | 241 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.0% | 512 | 496 | $3K |
| 80053 | Comprehensive metabolic panel | 3.0% | 377 | 368 | $3K |
| 86780 | 3.0% | 278 | 272 | $3K | |
| 87522 | Neg quan hep c or qual rna | 2.9% | 80 | 80 | $3K |
35 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | 2.9% | 434 | $3K |
| 36415 | Collection of venous blood by venipuncture | 2.4% | 1,458 | $3K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.3% | 122 | $2K |
| 86803 | 2.2% | 226 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 42 | $2K |
| 82607 | 1.7% | 147 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.4% | 217 | $1K |
| 86704 | 1.0% | 105 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 236 | $1K |
| 81001 | <1% | 277 | $720.32 | |
| 86705 | <1% | 68 | $709.64 | |
| 85027 | <1% | 125 | $672.37 | |
| 84439 | <1% | 86 | $650.56 | |
| 86706 | <1% | 76 | $548.78 | |
| 82728 | <1% | 45 | $513.90 | |
| 82746 | <1% | 58 | $513.66 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 28 | $487.50 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 13 | $382.46 |
| 84460 | <1% | 83 | $368.75 | |
| 84450 | <1% | 82 | $355.30 | |
| 83540 | <1% | 57 | $305.37 | |
| 80076 | <1% | 52 | $305.06 | |
| 84075 | <1% | 67 | $291.01 | |
| 82247 | <1% | 67 | $282.29 | |
| 84403 | <1% | 13 | $281.45 | |
| 87340 | <1% | 26 | $234.27 | |
| 84155 | <1% | 67 | $205.86 | |
| 82040 | <1% | 66 | $192.87 | |
| 86618 | <1% | 12 | $169.08 | |
| 84481 | <1% | 26 | $121.42 | |
| 82570 | <1% | 25 | $117.18 | |
| 83550 | <1% | 12 | $87.96 | |
| 82043 | <1% | 13 | $58.20 | |
| 82248 | <1% | 12 | $50.52 | |
| 85652 | <1% | 13 | $29.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.